Novo Nordisk to slash Wegovy prices by 50%, Ozempic by 35%

Novo Nordisk said Tuesday it will slash its prices for Wegovy and Ozempic beginning next year by up to 50%, highlighting the growing competition among pharmaceutical firms for customers seeking weight-loss drugs.  The Danish drugmaker said it plans to offer the medicines for $675 per month starting in January 2027, representing a 50% reduction in … Read more

Novo Nordisk to halve U.S. list price of Wegovy from 2027

Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year, the Danish drugmaker said on Tuesday. The price cuts will be effective January 1 next year, coinciding with the implementation of new, lower prices for the same drugs under federal Medicare … Read more